What other stocks do shareholders of Daxor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Daxor investors own include Gilead Sciences (GILD) , Inovio Pharmaceuticals (INO) , Novavax (NVAX) , Pfizer (PFE) , ContraFect (CFRX) , Dynavax Technologies (DVAX) , iBio (IBIO) , Micron Technology (MU) and

How do I buy shares of Daxor?

Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEAMERICAN:DXR

Daxor (DXR) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free DXR Stock Alerts

$9.61

+0.06 (+0.63%)

(As of 04/17/2024 ET)

Compare

Today's Range: $9.49
▼
$9.61
50-Day Range: N/A
52-Week Range: $7.11
▼
$13.13

Volume: 851 shs
Average Volume: 3,401 shs
Market Capitalization: $45.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines Ownership SEC Filings

Get Daxor alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Daxor Stock (NYSEAMERICAN:DXR)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

DXR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DXR Stock News Headlines

April 16, 2024 | finance.yahoo.com

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

April 15, 2024 | finance.yahoo.com

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 1, 2024 | finance.yahoo.com

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

March 29, 2024 | investing.com

Daxor CFO Michel Robert J buys $6.5k in company stock

March 28, 2024 | money.usnews.com

Destiny Tech100 Inc

March 28, 2024 | finance.yahoo.com

Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript

March 23, 2024 | wsj.com

Daxor Corp.

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 22, 2024 | finance.yahoo.com

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

March 8, 2024 | finance.yahoo.com

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients

February 12, 2024 | finance.yahoo.com

Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions

February 9, 2024 | benzinga.com

Daxor Stock (NASDAQ:DXR) Insider Trades

February 7, 2024 | finance.yahoo.com

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts

January 29, 2024 | finance.yahoo.com

Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting

January 16, 2024 | finance.yahoo.com

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress

January 9, 2024 | finance.yahoo.com

DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES

January 3, 2024 | msn.com

Daxor seeks US FDA approval for blood volume analyser

January 2, 2024 | finance.yahoo.com

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

November 13, 2023 | seekingalpha.com

Aspira Women’s Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68M

November 13, 2023 | finanznachrichten.de

Daxor Corporation: New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure Patients

November 13, 2023 | finance.yahoo.com

New Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure Patients

November 9, 2023 | finance.yahoo.com

Daxor Corporation Awarded New Patent for Remote Monitoring of Blood Volume

November 7, 2023 | msn.com

Neuronetics GAAP EPS of -$0.33 misses by $0.02, revenue of $17.9M beats by $0.32M

November 5, 2023 | benzinga.com

Chief Financial Officer at Daxor Acquires Company Stock Options Worth 5,000 Shares

October 13, 2023 | finance.yahoo.com

Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting

October 11, 2023 | finance.yahoo.com

New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meeting

See More Headlines

Receive DXR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daxor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Current Symbol: NYSEAMERICAN:DXR
Previous Symbol: NYSE:DXR
CUSIP: N/A
CIK: 27367
Web: www.daxor.com
Phone: (865) 425-0555
Fax: 212-244-0806
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 4,740,000
Free Float: 1,866,000
Market Cap: $45.57 million
Optionable: Not Optionable
Beta: -0.50

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Michael Richard Feldschuh (Age 55)
Chairman, President & CEO
Comp: $100k
Mr. Jonathan Adam Feldschuh (Age 59)
Chief Scientific Officer & Director
Comp: $127.92k
Mr. Robert J. Michel CPA (Age 67)
CPA, M.B.A., CFO, Chief Compliance Officer & Corporate Secretary
Ms. Linda Cooper
Vice President of Development & Operations
Ms. Kathryn A. Kornafel
Senior VP of Marketing & Commercial Development
Mr. Guido Manzo
Vice President of Sales
Ms. Jean Oertel
Senior Vice President Commercialization & Customer Experience

Key Competitors

View All Competitors

DXR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Daxor own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Daxor investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), ContraFect (CFRX), Dynavax Technologies (DVAX), iBio (IBIO), Micron Technology (MU) and
How do I buy shares of Daxor?: Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:DXR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial